Literature DB >> 9170432

Localization of parathyroid glands using technetium-99m-tetrofosmin imaging.

M Ishibashi1, H Nishida, H W Strauss, K Kojima, H Fujito, J Watanabe, Y Hiromatsu, N Hayabuchi.   

Abstract

UNLABELLED: Preoperative localization of hyperactive parathyroid glands is useful to minimize operative time and reduce patient morbidity. This investigation compared the sensitivity of radionuclide imaging with 99mTc tetrofosmin with that of ultrasonography and magnetic resonance (MR) imaging in patients with hyperparathyroidism.
METHODS: Twenty-six patients with primary (n = 7) or secondary (n = 19) hyperparathyroidism were imaged with 99mTc tetrofosmin, ultrasound and MR imaging of the neck and thorax to localize the lesions. The presence of hyperparathyroidism was identified by an intact parathyroid hormone in vitro assay. The parathyroid/normal thyroid tissue activity ratio was calculated for all patients with evidence of an abnormality on tetrofosmin images. Pathological findings were compared with the results of imaging in 18 of the 26 patients who underwent parathyroidectomy.
RESULTS: Technetium-99m tetrofosmin scans demonstrated focal uptake in 46 glands of 26 patients. The uptake was categorized as slight in 78.3% (36/46) and intense (parathyroid/normal thyroid tissue activity ratio, > 1.4) in 21.7% (10/46). Ultrasonography and MR imaging identified 44 and 47 glands, respectively, in these patients. Eleven of the 18 patients who underwent parathyroidectomy within 1 mo after tetrofosmin imaging had hyperplastic glands, while 7 had parathyroid adenomas. Tetrofosmin imaging successfully localized 7 of 7 (100%) adenomas and 27 of 37 (73.0%) hyperplastic glands. The sensitivities of each technique for localizing abnormal parathyroid glands were 77.3% (34/44) for tetrofosmin imaging: 68.2% (20/44) for ultrasonography: and 68.2% (30/44) for MR imaging. Technetium-99m tetrofosmin uptake ratio in the 18 patients with surgical exploration was not proportional to several oxyphil cells.
CONCLUSION: Technetium-99m tetrofosmin parathyroid imaging may be useful for localizing abnormal glands in patients with primary and secondary hyperparathyroidism. The sensitivity of 99mTc tetrofosmin parathyroid imaging was high as compared to ultrasonography or MR imaging. The prolonged retention of tetrofosmin may not depend on the number of mitochondria-rich oxyphil cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9170432

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  5 in total

1.  Brain tumor imaging with 99mTc-tetrofosmin: comparison with 201Tl, 99mTc-MIBI, and 18F-fluorodeoxyglucose.

Authors:  J Y Choi; S E Kim; H J Shin; B T Kim; J H Kim
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

2.  The value of Tc-99m tetrofosmin in the imaging of pituitary adenomas.

Authors:  N Kurtulmus; C Turkmen; S Yarman; H Tokmak; A Mudun
Journal:  J Endocrinol Invest       Date:  2007-02       Impact factor: 4.256

3.  Oxyphil cells in primary hyperparathyroidism: a clinicopathological study.

Authors:  Ángela De la Hoz Rodríguez; José Luis Muñoz De Nova; Patricia Muñoz Hernández; Álvaro Valdés de Anca; Rosario Serrano Pardo; Rodrigo Tovar Pérez; Elena Martín-Pérez
Journal:  Hormones (Athens)       Date:  2021-07-06       Impact factor: 2.885

Review 4.  Sporadic multiple parathyroid gland disease--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Marcin Barczyński; Robert Bränström; Gianlorenzo Dionigi; Radu Mihai
Journal:  Langenbecks Arch Surg       Date:  2015-11-05       Impact factor: 3.445

5.  Comparison of scintigraphy and ultrasound imaging in patients with primary, secondary and tertiary hyperparathyroidism - own experience.

Authors:  Małgorzata Kobylecka; Maria Teresa Płazińska; Witold Chudziński; Katarzyna Fronczewska-Wieniawska; Joanna Mączewska; Adam Bajera; Maria Karlińska; Leszek Królicki
Journal:  J Ultrason       Date:  2017-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.